Arrowstreet Capital’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-23,475
| Closed | -$1.64M | – | 1898 |
|
|
2019
Q1 | $1.64M | Sell |
23,475
-11,964
| -34% | -$838K | ﹤0.01% | 1167 |
|
|
2018
Q4 | $2.28M | Buy |
+35,439
| New | +$2.28M | 0.01% | 754 |
|
|
2015
Q3 | – | Sell |
-36,812
| Closed | -$1.02M | – | 1565 |
|
|
2015
Q2 | $1.02M | Buy |
+36,812
| New | +$1.02M | 0.01% | 810 |
|
|
2014
Q3 | – | Sell |
-18,807
| Closed | -$515K | – | 1187 |
|
|
2014
Q2 | $515K | Sell |
18,807
-20,882
| -53% | -$572K | ﹤0.01% | 821 |
|
|
2014
Q1 | $1.05M | Sell |
39,689
-37,269
| -48% | -$981K | 0.01% | 819 |
|
|
2013
Q4 | $2.25M | Buy |
76,958
+41,937
| +120% | +$1.23M | 0.01% | 633 |
|
|
2013
Q3 | $1.07M | Buy |
35,021
+17,906
| +105% | +$548K | 0.01% | 654 |
|
|
2013
Q2 | $543K | Buy |
+17,115
| New | +$543K | ﹤0.01% | 625 |
|